FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018618270> ?p ?o ?g. }

• W2018618270 endingPage "147" @default.
• W2018618270 startingPage "139" @default.
• W2018618270 abstract "Malignant glioma is a rare tumor type characterized by prominent vascular proliferation. Antiangiogenic therapy with the monoclonal antibody bevacizumab is considered as a promising therapeutic strategy, although the effect on tumor vascularization is unclear. High-field susceptibility-weighted imaging (SWI) visualizes the microvasculature and may contribute to the investigation of antiangiogenic therapy responses in gliomas. We prospectively studied five adult malignant glioma patients treated with bevacizumab-containing regimens. In each patient, we performed three 7-T SWI and T1-weighted imaging investigations (baseline and 2 and 4 weeks after the start of bevacizumab treatment). In addition, we imaged a postmortem brain of a patient with glioblastoma using 7-T SWI and performed detailed histopathological analysis. We observed almost total resolution of brain edema in three of five patients after initiation of bevacizumab therapy. In one case with rapid increase of the lesion size despite bevacizumab therapy, SWI showed progressive increase of irregular hypointense structures, most likely corresponding to increasing amounts of pathological microvasculature. In one case with progressive neurological decline, 7-T images showed multiple intratumoral microhemorrhages after the first bevacizumab application. Correlation of postmortem neuroimaging with histopathology confirmed that SWI-positive structures correspond to tumor vasculature. The experience from our case series indicates that longitudinal 7-T SWI seems to be an appropriate method for investigation of changes in brain tumor vascularization over time under antiangiogenic therapy." @default.
• W2018618270 created "2016-06-24" @default.
• W2018618270 creator A5006042062 @default.
• W2018618270 creator A5007120537 @default.
• W2018618270 creator A5008270749 @default.
• W2018618270 creator A5009274288 @default.
• W2018618270 creator A5041960154 @default.
• W2018618270 creator A5053746026 @default.
• W2018618270 creator A5057141936 @default.
• W2018618270 creator A5073287874 @default.
• W2018618270 creator A5082898801 @default.
• W2018618270 date "2012-01-01" @default.
• W2018618270 modified "2023-10-07" @default.
• W2018618270 title "Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T" @default.
• W2018618270 cites W1527943568 @default.
• W2018618270 cites W1603230122 @default.
• W2018618270 cites W1978041336 @default.
• W2018618270 cites W1980960868 @default.
• W2018618270 cites W1984036240 @default.
• W2018618270 cites W2000878453 @default.
• W2018618270 cites W2002396011 @default.
• W2018618270 cites W2002727873 @default.
• W2018618270 cites W2054348646 @default.
• W2018618270 cites W2072589309 @default.
• W2018618270 cites W2076182555 @default.
• W2018618270 cites W2080657715 @default.
• W2018618270 cites W2081064993 @default.
• W2018618270 cites W2083839350 @default.
• W2018618270 cites W2086883291 @default.
• W2018618270 cites W2096847489 @default.
• W2018618270 cites W2097351556 @default.
• W2018618270 cites W2106263593 @default.
• W2018618270 cites W2114830364 @default.
• W2018618270 cites W2132697290 @default.
• W2018618270 cites W2141260326 @default.
• W2018618270 cites W2146336531 @default.
• W2018618270 cites W2157500906 @default.
• W2018618270 cites W2160382843 @default.
• W2018618270 cites W2162643152 @default.
• W2018618270 cites W2164049072 @default.
• W2018618270 cites W2167418009 @default.
• W2018618270 doi "https://doi.org/10.1016/j.mri.2011.08.004" @default.
• W2018618270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21982163" @default.
• W2018618270 hasPublicationYear "2012" @default.
• W2018618270 type Work @default.
• W2018618270 sameAs 2018618270 @default.
• W2018618270 citedByCount "36" @default.
• W2018618270 countsByYear W20186182702012 @default.
• W2018618270 countsByYear W20186182702013 @default.
• W2018618270 countsByYear W20186182702014 @default.
• W2018618270 countsByYear W20186182702015 @default.
• W2018618270 countsByYear W20186182702016 @default.
• W2018618270 countsByYear W20186182702017 @default.
• W2018618270 countsByYear W20186182702019 @default.
• W2018618270 countsByYear W20186182702021 @default.
• W2018618270 countsByYear W20186182702022 @default.
• W2018618270 crossrefType "journal-article" @default.
• W2018618270 hasAuthorship W2018618270A5006042062 @default.
• W2018618270 hasAuthorship W2018618270A5007120537 @default.
• W2018618270 hasAuthorship W2018618270A5008270749 @default.
• W2018618270 hasAuthorship W2018618270A5009274288 @default.
• W2018618270 hasAuthorship W2018618270A5041960154 @default.
• W2018618270 hasAuthorship W2018618270A5053746026 @default.
• W2018618270 hasAuthorship W2018618270A5057141936 @default.
• W2018618270 hasAuthorship W2018618270A5073287874 @default.
• W2018618270 hasAuthorship W2018618270A5082898801 @default.
• W2018618270 hasConcept C118552586 @default.
• W2018618270 hasConcept C126322002 @default.
• W2018618270 hasConcept C126838900 @default.
• W2018618270 hasConcept C142724271 @default.
• W2018618270 hasConcept C143409427 @default.
• W2018618270 hasConcept C16246696 @default.
• W2018618270 hasConcept C207886595 @default.
• W2018618270 hasConcept C2776694085 @default.
• W2018618270 hasConcept C2777802072 @default.
• W2018618270 hasConcept C2778227246 @default.
• W2018618270 hasConcept C2779130545 @default.
• W2018618270 hasConcept C2781156865 @default.
• W2018618270 hasConcept C502942594 @default.
• W2018618270 hasConcept C544855455 @default.
• W2018618270 hasConcept C58693492 @default.
• W2018618270 hasConcept C71924100 @default.
• W2018618270 hasConceptScore W2018618270C118552586 @default.
• W2018618270 hasConceptScore W2018618270C126322002 @default.
• W2018618270 hasConceptScore W2018618270C126838900 @default.
• W2018618270 hasConceptScore W2018618270C142724271 @default.
• W2018618270 hasConceptScore W2018618270C143409427 @default.
• W2018618270 hasConceptScore W2018618270C16246696 @default.
• W2018618270 hasConceptScore W2018618270C207886595 @default.
• W2018618270 hasConceptScore W2018618270C2776694085 @default.
• W2018618270 hasConceptScore W2018618270C2777802072 @default.
• W2018618270 hasConceptScore W2018618270C2778227246 @default.
• W2018618270 hasConceptScore W2018618270C2779130545 @default.
• W2018618270 hasConceptScore W2018618270C2781156865 @default.
• W2018618270 hasConceptScore W2018618270C502942594 @default.
• W2018618270 hasConceptScore W2018618270C544855455 @default.
• W2018618270 hasConceptScore W2018618270C58693492 @default.
• W2018618270 hasConceptScore W2018618270C71924100 @default.

• next